A Novel Combination of Serum Markers in a Multivariate Model to Help Triage Patients Into "Low-" and "High-Risk" Categories for Prostate Cancer.

McNally, Christopher J; Watt, Joanne; Kurth, Mary Jo; Lamont, John V; Moore, Tara; Fitzgerald, Peter; Pandha, Hardev; McKenna, Declan J; Ruddock, Mark W

McNally, Christopher J; Watt, Joanne; Kurth, Mary Jo; Lamont, John V; Moore, Tara; Fitzgerald, Peter; Pandha, Hardev; McKenna, Declan J; Ruddock, Mark W.

Afiliación

McNally CJ; Genomic Medicine Research Group, Ulster University, Coleraine, United Kingdom.
Watt J; Clinical Studies Group, Randox Laboratories Ltd., Crumlin, United Kingdom.
Kurth MJ; Clinical Studies Group, Randox Laboratories Ltd., Crumlin, United Kingdom.
Lamont JV; Clinical Studies Group, Randox Laboratories Ltd., Crumlin, United Kingdom.
Moore T; Genomic Medicine Research Group, Ulster University, Coleraine, United Kingdom.
Fitzgerald P; Clinical Studies Group, Randox Laboratories Ltd., Crumlin, United Kingdom.
Pandha H; Royal Surrey County Hospital NHS Foundation Trust, Research Development and Innovations Department, The Royal Surrey County Hospital, Guildford, United Kingdom.
McKenna DJ; School of Biosciences and Medicine, Faculty of Health and Medical Sciences, University of Surrey, Guildford, United Kingdom.
Ruddock MW; Genomic Medicine Research Group, Ulster University, Coleraine, United Kingdom.

Front Oncol ; 12: 837127, 2022.

Article en En | MEDLINE | ID: mdl-35664747

Palabras clave

EGF; IL-8; MCP-1; algorithm; fPSA; marker; prostate cancer; tPSA

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google